Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.01B | 12.84B | 12.89B | 12.59B | 11.57B | 10.84B |
Gross Profit | 2.19B | 2.16B | 2.28B | 2.31B | 2.15B | 1.96B |
EBITDA | 433.57M | 797.05M | 828.20M | 655.18M | 873.32M | 965.24M |
Net Income | 104.12M | 148.63M | 249.24M | 117.14M | 190.79M | 179.78M |
Balance Sheet | ||||||
Total Assets | 17.42B | 16.87B | 17.01B | 16.99B | 15.64B | 16.60B |
Cash, Cash Equivalents and Short-Term Investments | 2.52B | 2.39B | 3.15B | 3.65B | 3.26B | 3.46B |
Total Debt | 2.74B | 2.30B | 2.03B | 2.66B | 1.98B | 2.35B |
Total Liabilities | 7.41B | 6.66B | 7.02B | 7.29B | 6.34B | 6.79B |
Stockholders Equity | 9.64B | 9.80B | 9.62B | 9.30B | 8.90B | 9.43B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -617.93M | 180.74M | -226.84M | 201.83M | 708.77M |
Operating Cash Flow | 0.00 | 246.92M | 508.99M | 464.80M | 529.34M | 1.08B |
Investing Cash Flow | 0.00 | -1.17B | -345.73M | -745.35M | -441.94M | -431.48M |
Financing Cash Flow | 0.00 | 116.41M | -762.08M | 606.48M | -478.57M | -306.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥2.94B | 8.20 | 3.13% | 10.31% | 77.52% | ||
67 Neutral | ¥4.01B | 18.23 | 1.00% | 11.25% | 58.54% | ||
63 Neutral | ¥3.04B | 20.15 | 2.20% | -0.35% | -39.20% | ||
56 Neutral | ¥2.61B | 43,540.30 | 1.42% | 4.98% | 99.38% | ||
46 Neutral | ¥4.31B | 521.41 | 3.00% | -3.17% | -21.99% | ||
44 Neutral | C$982.42M | -6.71 | -13.24% | 2.54% | 17.20% | -32.72% |